1. Home
  2. SDRL vs NKTR Comparison

SDRL vs NKTR Comparison

Compare SDRL & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seadrill Limited

SDRL

Seadrill Limited

HOLD

Current Price

$39.91

Market Cap

2.4B

Sector

Energy

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$72.28

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDRL
NKTR
Founded
2005
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
SDRL
NKTR
Price
$39.91
$72.28
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$56.00
$146.67
AVG Volume (30 Days)
1.0M
1.2M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
54.61
N/A
EPS
N/A
N/A
Revenue
$1,437,000,000.00
$307,711,000.00
Revenue This Year
$5.22
N/A
Revenue Next Year
$16.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.75
86.00
52 Week Low
$27.40
$21.02
52 Week High
$55.47
$109.00

Technical Indicators

Market Signals
Indicator
SDRL
NKTR
Relative Strength Index (RSI) 44.29 58.44
Support Level $28.94 $64.30
Resistance Level $40.16 $76.67
Average True Range (ATR) 1.63 4.21
MACD 0.41 1.49
Stochastic Oscillator 75.28 71.74

Price Performance

Historical Comparison
SDRL
NKTR

About SDRL Seadrill Limited

Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: